HSBC Holdings
OLMA icon

HSBC Holdings’s Olema Pharmaceuticals OLMA Stock Holding History

HSBC Holdings’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,179
Closed -$343K – 3096
2025
Q3 		$343K Sell
35,179
-2,454
-7% -$14.7K ﹤0.01% 2280
2025
Q2 		$174K Buy
37,633
+21,935
+140% +$97.8K ﹤0.01% 2721
2025
Q1 		$57.8K Buy
15,698
+5,693
+57% +$28.6K ﹤0.01% 2889
2024
Q4 		$58.2K Buy
+10,005
New +$99.9K ﹤0.01% 2970
2023
Q2 		– Sell
-10,150
Closed -$37.1K – 2690
2023
Q1 		$37.1K Hold
10,150
– – ﹤0.01% 2584
2022
Q4 		$26.1K Hold
10,150
– – ﹤0.01% 3004
2022
Q3 		$28K Hold
10,150
– – ﹤0.01% 2858
2022
Q2 		$42K Buy
+10,150
New +$32.2K ﹤0.01% 3156

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HSBC Holdings's OLMA Position: Q4 2025 in Review

HSBC Holdings sold out of Olema Pharmaceuticals (OLMA) in Q4 2025, closing a stake of 35,179 shares — an estimated $343K sold.

HSBC Holdings first reported a position in OLMA in Q2 2022 and held it in 8 quarters. The position peaked at $343K in Q3 2025. 200 funds tracked by Wall St. Rank hold OLMA as of Q4 2025.

  • HSBC Holdings reported no remaining Olema Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • HSBC Holdings sold 35,179 Olema Pharmaceuticals shares in Q4 2025, an estimated $343K.
  • HSBC Holdings first reported a position in Olema Pharmaceuticals in Q2 2022 and held it in 8 quarters.
  • HSBC Holdings's Olema Pharmaceuticals position peaked at $343K in Q3 2025.
  • 200 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2025.

Based on HSBC Holdings's 13F filing for Q4 2025, filed 6 Mar 2026.